| 6th Jun 2019 7:00 am |
RNS |
Disclosure Update |
| 31st May 2019 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 31st May 2019 4:35 pm |
RNS |
Price Monitoring Extension |
| 29th May 2019 12:06 pm |
RNS |
Results of Extraordinary General Meeting |
| 22nd May 2019 11:03 am |
RNS |
Grant of Share Options under Share Option Scheme |
| 3rd May 2019 7:00 am |
RNS |
Notice of EGM & Shareholder Circular |
| 24th Apr 2019 1:54 pm |
RNS |
Results of AGM |
| 15th Apr 2019 7:30 am |
RNS |
Disclosure Update |
| 15th Apr 2019 7:00 am |
RNS |
HK Listing Application - Proposed Global Offering |
| 29th Mar 2019 7:00 am |
RNS |
Start of Phase IIb/III Surufatinib Trial in China |
| 28th Mar 2019 7:30 am |
RNS |
Savolitinib Lung Cancer Presentations at AACR |
| 25th Mar 2019 7:00 am |
RNS |
Vesting of awards under Long Term Incentive Plan |
| 21st Mar 2019 7:00 am |
RNS |
Chi-Med 2018 Annual Report and Notice of AGM |
| 11th Mar 2019 12:54 pm |
RNS |
Publication of Form 20-F |
| 11th Mar 2019 7:00 am |
RNS |
2018 FY Results and Key Clinical Programs Update |
| 12th Feb 2019 7:00 am |
RNS |
Savolitinib PRCC Data to be presented at ASCO GU |
| 8th Feb 2019 7:00 am |
RNS |
Chi-Med to Announce 2018 Final Results |
| 7th Jan 2019 7:00 am |
RNS |
Chi-Med Presents at JPM Healthcare Conference |
| 31st Dec 2018 7:00 am |
RNS |
Blocklisting Six Monthly Return |
| 31st Dec 2018 7:00 am |
RNS |
Total Voting Rights |
| 24th Dec 2018 12:41 pm |
RNS |
Second Price Monitoring Extn |
| 24th Dec 2018 12:36 pm |
RNS |
Price Monitoring Extension |
| 20th Dec 2018 7:13 am |
RNS |
Chi-Med announce Savolitinib program update |
| 20th Dec 2018 7:00 am |
RNS |
Amendment to Lilly Agreement on Fruquintinib |
| 14th Dec 2018 7:21 am |
RNS |
TR-1: Form for notification of major holdings |
| 30th Nov 2018 7:00 am |
RNS |
Total Voting Rights |
| 29th Nov 2018 8:00 am |
RNS |
Chi-Med Enters into Multiple Collaborations |
| 26th Nov 2018 7:00 am |
RNS |
First Commercial Launch of Fruquintinib Capsules |
| 16th Nov 2018 7:00 am |
RNS |
Phase III FALUCA Trial Results for Fruquintinib |
| 31st Oct 2018 7:00 am |
RNS |
Total Voting Rights |
| 22nd Oct 2018 10:05 am |
RNS |
Grant of Share Options under Share Option Scheme |
| 18th Oct 2018 7:00 am |
RNS |
Chi-Med Initiates a Ph I Trial of HMPL-523 for AML |
| 5th Oct 2018 7:00 am |
RNS |
Appointment of HSBC Bank plc as Broker in London |
| 5th Sep 2018 7:00 am |
RNS |
Fruquintinib Approved for CRC in China |
| 31st Aug 2018 7:00 am |
RNS |
Total Voting Rights |
| 7th Aug 2018 10:00 am |
RNS |
Grant of Share Options under Share Option Scheme |
| 27th Jul 2018 7:00 am |
RNS |
2018 Interim Results and Clinical Programs Update |
| 23rd Jul 2018 7:00 am |
RNS |
Start of Sulfatinib US Phase Ib/II PoC trial |
| 29th Jun 2018 7:02 am |
RNS |
Total Voting Rights |
| 29th Jun 2018 7:01 am |
RNS |
Blocklisting Six Monthly Return |
